DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) is a blank check company that completed its initial public offering in 2021, targeting acquisition opportunities within the life science and healthcare technology sectors. As reflected in its 10-Q filed with the SEC on November 15, 2021, the company was in the business combination search phase at that time, having not yet announced a definitive merger agreement with a target. DALS represents a sector-specific vehicle designed to identify and combine with businesses operating at the intersection of life sciences and technology innovation. To access full filing history, sponsor details, and deal-status tracking for DALS and hundreds of other SPACs, sign up for complete data on SpacDesk.